News from alcyone lifesciences, inc. A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Dec 02, 2019, 09:30 ET Bringing Hope to Spinal Muscular Atrophy (SMA) Patients with the Alcyone Lifesciences ThecaFlex DRx™ System Breakthrough Device

Alcyone Lifesciences, Inc., a biotechnology company dedicated to precision administered genetic therapies to treat complex neurological and...

Dec 02, 2019, 08:30 ET Alcyone Lifesciences to Present at Piper Jaffray 31st Annual Healthcare Conference

Alcyone Lifesciences, Inc., a biotechnology company dedicated to precision administered genetic therapies to treat complex neurological and...

Dec 20, 2018, 08:30 ET Alcyone Lifesciences Announces Broad Strategic Collaboration with Roche in the Field of Intrathecal Therapies

Alcyone Lifesciences, Inc., a leader in breakthrough technologies to treat complex neurological and oncological conditions through the company's...

Nov 26, 2018, 09:00 ET Alcyone Lifesciences Announces the Use of AMC Intratumoral Delivery Platform in the Treatment of First Patient in DNX-2440 Glioblastoma Trial

Alcyone Lifesciences, Inc., a leader in breakthrough technologies to treat complex oncolytic and neurological conditions through the company's...

Jul 03, 2018, 08:30 ET Promising Treatment of Challenging Pediatric Brain Stem Tumor, DIPG, with Alcyone AMC Precision Delivery of Oncolytic Adenovirus

Alcyone Lifesciences, Inc., a leader in transforming Disease Modifying Therapies for CNS through Advanced Precision Delivery Platforms, announced...

May 15, 2018, 08:30 ET Alcyone Lifesciences Announces Presentation on Intrathecal Physical Methods of Delivery of Gene Therapeutics at 2018 American Society of Cell and Gene Therapy Conference

Alcyone Lifesciences, Inc., a leader in disease modifying therapies for the central nervous system (CNS) through its Advanced Precision Delivery...

Feb 20, 2018, 09:00 ET Alcyone Lifesciences Completes Spin-Off of Hydrocephalus Business, Anuncia

Alcyone Lifesciences, Inc., a privately-held company focused on transforming disease modifying therapies for central nervous system (CNS) disorders...

Jan 08, 2018, 08:00 ET Alcyone Lifesciences Announces Research Collaboration with a Leading Biopharmaceutical Company to Improve Intrathecal Delivery of Therapies for Rare and Orphan Neurological Conditions

Alcyone Lifesciences, Inc., a privately-held company focused on transforming disease modifying therapies for central nervous system (CNS) disorders...

Dec 07, 2017, 08:00 ET Alcyone Lifesciences Announces First Pediatric Patient Treated with AMC for Treatment of DIPG

Alcyone Lifesciences, Inc., a leader in transforming Disease Modifying Therapies for the central nervous system (CNS) through Advanced Precision...

Nov 15, 2017, 07:00 ET Alcyone Lifesciences Receives FDA Clearance for the Alivio System for the Treatment of Hydrocephalus

Alcyone Lifesciences, Inc., announced that the U.S. Food and Drug Administration (FDA) cleared the Alivio Ventricular Catheter & Flusher System...

Oct 24, 2017, 09:00 ET Alcyone Lifesciences Receives EU CE Mark Approval for Alivio Ventricular Catheter and Flusher System for Treatment of Hydrocephalus

Alcyone Lifesciences, Inc., a leader in advanced precision delivery for neurological conditions, and innovator in the treatment of hydrocephalus,...

Jun 29, 2017, 08:30 ET Alcyone Lifesciences Enters into a Feasibility Study Agreement with Pfizer to Evaluate Alcyone's proprietary Pulsar™ Advanced Intrathecal Precision Delivery Platform Technology for use in Gene Therapy Targeting Central Nervous System Disorders

Alcyone Lifesciences, Inc., a leader in precision advanced central nervous system (CNS) delivery systems announced that it has entered into a...

Aug 09, 2016, 08:30 ET Alcyone Lifesciences, Inc. Announces Allowance of First Patent Related to ReFlow™ System for the Treatment of Hydrocephalus

Alcyone Lifesciences, Inc., a leader in neural intervention systems for neurological conditions and an innovator in the treatment of hydrocephalus,...

Aug 02, 2016, 08:30 ET Alcyone Lifesciences Announces Clinical Use of the ReFlow™ System for the Treatment of Hydrocephalus

Alcyone Lifesciences, Inc., a leader in neural intervention systems for neurological conditions and an innovator in the treatment of hydrocephalus,...

Jul 07, 2015, 07:00 ET Dr. Olivier Danos, Cell and Gene Therapy Pioneer, Joins Alcyone Lifesciences Scientific Advisory Board

Alcyone Lifesciences, Inc., a leader in neural intervention systems for neurological conditions, today announced that Olivier Danos, Ph.D., senior...